Prognostic implication and biological roles of RhoH in acute myeloid leukaemia

European Journal of Haematology

Volumn 81, Issue 6, 2008, Pages 454-460

  Iwasaki, Toshihiro ^a   Katsumi, Akira ^a   Kiyoi, Hitoshi ^a   Tanizaki, Ryohei ^a   Ishikawa, Yuichi ^a   Ozeki, Kazutaka ^a   Kobayashi, Miki ^a   Abe, Akihiro ^a   Matsushita, Tadashi ^a   Watanabe, Takashi ^a   Amano, Mutsuki ^a   Kojima, Tetsuhito ^a   Kaibuchi, Kozo ^a   Naoe, Tomoki ^a  

^a NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Acute myeloid leukaemia; Gene expression; Prognosis; Rac; RhoH

Indexed keywords

GUANINE NUCLEOTIDE BINDING PROTEIN; RAC PROTEIN; RHO FACTOR; RHOH PROTEIN; SERINE; UNCLASSIFIED DRUG;

ACUTE GRANULOCYTIC LEUKEMIA; ADOLESCENT; ADULT; AGED; ARTICLE; BONE MARROW; CHEMOTHERAPY; CONTROLLED STUDY; DISEASE FREE SURVIVAL; FLUORESCENCE; GENE EXPRESSION; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; KAPLAN MEIER METHOD; MAJOR CLINICAL STUDY; MULTIVARIATE ANALYSIS; OVERALL SURVIVAL; PRIORITY JOURNAL; PROGNOSIS; PROTEIN DEPHOSPHORYLATION; PROTEIN EXPRESSION;

ADULT; BONE MARROW; DISEASE-FREE SURVIVAL; FEMALE; GENE EXPRESSION REGULATION, ENZYMOLOGIC; GENE EXPRESSION REGULATION, LEUKEMIC; HEMATOPOIETIC STEM CELLS; HUMANS; LEUKEMIA, MYELOID, ACUTE; MALE; NEOPLASM PROTEINS; PREDICTIVE VALUE OF TESTS; PROTO-ONCOGENE PROTEINS C-AKT; RHO GTP-BINDING PROTEINS; RNA, MESSENGER; RNA, NEOPLASM; SURVIVAL RATE; T-LYMPHOCYTES; TRANSCRIPTION FACTORS; TRANSCRIPTION, GENETIC; ZAP-70 PROTEIN-TYROSINE KINASE;

EID: 56649092609     PISSN: 09024441     EISSN: 16000609     Source Type: Journal    
DOI: 10.1111/j.1600-0609.2008.01132.x     Document Type: Article

References (26)

1. Dallery E, Galiegue-Zouitina S, Collyn-d'Hooghe M, et al. TTF, a gene encoding a novel small G protein, fuses to the lymphoma-associated LAZ3 gene by t(3;4) chromosomal translocation. Oncogene 1995 10 : 2171 8.
2. Pasqualucci L, Neumeister P, Goossens T, Nanjangud G, Chaganti RS, Kuppers R, Dalla-Favera R. Hypermutation of multiple proto-oncogenes in B-cell diffuse large-cell lymphomas. Nature 2001 412 : 341 6.
3. Hiraga J, Katsumi A, Iwasaki T, Abe A, Kiyoi H, Matsushita T, Kinoshita T, Naoe T. Prognostic analysis of aberrant somatic hypermutation of RhoH gene in diffuse large B cell lymphoma. Leukemia 2007 21 : 2146 7.
4. Gu Y, Jasti AC, Jansen M, Siefring JE. RhoH, a hematopoietic-specific Rho GTPase, regulates proliferation, survival, migration, and engraftment of hematopoietic progenitor cells. Blood 2005 105 : 1467 75.
5. Cherry LK, Li X, Schwab P, Lim B, Klickstein LB. RhoH is required to maintain the integrin LFA-1 in a nonadhesive state on lymphocytes. Nat Immunol 2004 5 : 961 7.
6. Dorn T, Kuhn U, Bungartz G, et al. RhoH is important for positive thymocyte selection and T-cell receptor signaling. Blood 2007 109 : 2346 55.
7. Gu Y, Chae HD, Siefring JE, Jasti AC, Hildeman DA, Williams DA. RhoH GTPase recruits and activates Zap70 required for T cell receptor signaling and thymocyte development. Nat Immunol 2006 7 : 1182 90.
8. Li X, Bu X, Lu B, Avraham H, Flavell RA, Lim B. The hematopoiesis- specific GTP-binding protein RhoH is GTPase deficient and modulates activities of other Rho GTPases by an inhibitory function. Mol Cell Biol 2002 22 : 1158 71.
9. Grimwade D, Walker H, Oliver F, et al. The importance of diagnostic cytogenetics on outcome in AML: analysis of 1612 patients entered into the MRC AML 10 trial. The Medical Research Council Adult and Children's Leukaemia Working Parties. Blood 1998 92 : 2322 33.
10. Ohno R, Kobayashi T, Tanimoto M, et al. Randomized study of individualized induction therapy with or without vincristine, and of maintenance-intensification therapy between 4 or 12 courses in adult acute myeloid leukemia. AML-87 Study of the Japan Adult Leukemia Study Group. Cancer 1993 71 : 3888 95.
11. Kobayashi T, Miyawaki S, Tanimoto M, et al. Randomized trials between behenoyl cytarabine and cytarabine in combination induction and consolidation therapy, and with or without ubenimex after maintenance/intensification therapy in adult acute myeloid leukemia. The Japan Leukemia Study Group. J Clin Oncol 1996 14 : 204 13.
12. Miyawaki S, Tanimoto M, Kobayashi T, et al. o beneficial effect from addition of etoposide to daunorubicin, cytarabine, and 6-mercaptopurine in individualized induction therapy of adult acute myeloid leukemia: the JALSG-AML92 study. Japan Adult Leukemia Study Group. Int J Hematol 1999 70 : 97 104.
13. Ozeki K, Kiyoi H, Hirose Y, et al. Biologic and clinical significance of the FLT3 transcript level in acute myeloid leukemia. Blood 2004 103 : 1901 8.
14. Kiyoi H, Naoe T, Yokota S, et al. Internal tandem duplication of FLT3 associated with leukocytosis in acute promyelocytic leukemia. Leukemia Study Group of the Ministry of Health and Welfare (Kohseisho). Leukemia 1997 11 : 1447 52.
15. Yamamoto Y, Kiyoi H, Nakano Y, et al. Activating mutation of D835 within the activation loop of FLT3 in human hematologic malignancies. Blood 2001 97 : 2434 9.
16. Kiyoi H, Naoe T, Nakano Y, et al. Prognostic implication of FLT3 and N-RAS gene mutations in acute myeloid leukemia. Blood 1999 93 : 3074 80.
17. Suzuki T, Kiyoi H, Ozeki K, et al. Clinical characteristics and prognostic implications of NPM1 mutations in acute myeloid leukemia. Blood 2005 106 : 2854 61.
18. Katsumi A, Milanini J, Kiosses WB, del Pozo MA, Kaunas R, Chien S, Hahn KM, Schwartz MA. Effects of cell tension on the small GTPase Rac. J Cell Biol 2002 158 : 153 64.
19. Slovak ML, Kopecky KJ, Cassileth PA, et al. Karyotypic analysis predicts outcome of preremission and postremission therapy in adult acute myeloid leukemia: a Southwest Oncology Group/Eastern Cooperative Oncology Group Study. Blood 2000 96 : 4075 83.
20. van Leeuwen FN, van der Kammen RA, Habets GG, Collard JG. Oncogenic activity of Tiam1 and Rac1 in NIH3T3 cells. Oncogene 1995 11 : 2215 21.
21. Zhang B, Zhang Y, Shacter E. Rac1 inhibits apoptosis in human lymphoma cells by stimulating Bad phosphorylation on Ser-75. Mol Cell Biol 2004 24 : 6205 14.
22. Chae HD, Lee KE, Williams DA, Gu Y. Cross-talk between RhoH and Rac1 in regulation of actin cytoskeleton and chemotaxis of hematopoietic progenitor cells. Blood 2008 111 : 2597 605.
23. Rapp UR, Fischer A, Rennefahrt UE, Hekman M, Albert S. BAD association with membranes is regulated by Raf kinases and association with 14-3-3 proteins. Adv Enzyme Regul 2007 47 : 281 5.
24. Schnelzer A, Prechtel D, Knaus U, Dehne K, Gerhard M, Graeff H, Harbeck N, Schmitt M, Lengyel E. Rac1 in human breast cancer: overexpression, mutation analysis, and characterization of a new isoform, Rac1b. Oncogene 2000 19 : 3013 20.
25. Sahai E, Marshall CJ. RHO-GTPases and cancer. Nat Rev Cancer 2002 2 : 133 42.
26. Sun D, Xu D, Zhang B. Rac signaling in tumorigenesis and as target for anticancer drug development. Drug Resist Updat 2006 9 : 274 87.